CLINICAL_TRIALS
trial_result
· 2015-12-14
Clinical Trial Update: A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis [Phase 3]
Summary
A Phase 3 confirmatory trial of TAU-284 in pediatric patients with perennial allergic rhinitis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2015-12-14